AstraZeneca's Datroway boosts survival in advanced breast cancer trial

AstraZeneca said on Monday its precision drug Datroway improved overall survival and progression free survival in patients with an advanced form of breast cancer versus chemotherapy in a trial when given early during treatment. ...